SJE-28126-40024
3 vaccinations
4 coded responses
37 check-ins
3 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 372 / TN
- Registered
- 2021-03-24
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-24
Registered in v-safe
-
2021-03-24
Dose 1 — Pfizer-BioNTech
-
2021-03-24
Survey response — day 0, dose 1MedDRA: Feeling abnormal — Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to workFree text: DazedMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-25
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain, Redness · Fatigue or tirednessAdult check-in
-
2021-03-26
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-03-27
- 2021-03-28
- 2021-03-29
- 2021-03-30
- 2021-03-31
- 2021-04-07
-
2021-04-14
Dose 2 — Pfizer-BioNTech
- 2021-04-14
-
2021-04-15
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness · Be unable to workAdult check-in
- 2021-04-16
- 2021-04-17
- 2021-04-19
- 2021-04-20
- 2021-04-21
- 2021-04-28
- 2021-05-05
- 2021-05-12
- 2021-05-19
- 2021-05-26
- 2021-07-14
- 2021-10-13
- 2022-04-14
-
2022-05-09
Dose 3 — Pfizer-BioNTech
- 2022-05-11
- 2022-05-12
- 2022-05-13
- 2022-05-14
- 2022-05-16
- 2022-05-26
-
2022-05-30
Survey response — day 21, dose 3MedDRA: Cough, Fatigue, Nasal congestion — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Stuffy nose, slight cough, fatigue.MedDRA releases: 2024-11 · check-in free text available
-
2022-06-06
Survey response — day 28, dose 3MedDRA: Brain fog, Fatigue, Sinusitis — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Sinus infection, brain fog and fatigueMedDRA releases: 2024-11 · check-in free text available
- 2022-06-13
- 2022-06-20
- 2022-08-08
- 2022-11-09
-
2023-05-12
Survey response — 12 months, dose 3MedDRA: Nasopharyngitis — Feeling: Fair · Be unable to do your normal daily activitiesMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-24 | Pfizer-BioNTech | |
| 2 | 2021-04-14 | Pfizer-BioNTech | |
| 3 | 2022-05-09 | Pfizer-BioNTech | No |
Free text
Release 6 — day 0, dose 1
Systemic reaction (other): Dazed
Release 11 — day 21, dose 3
Symptoms: Stuffy nose, slight cough, fatigue.
Release 11 — day 28, dose 3
Symptoms: Sinus infection, brain fog and fatigue
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Brain fog | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Sinusitis | · | · | ✓ |
| SRO | Feeling abnormal | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release